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Summary.-The development of serum factors by Wistar rats during the growth of
a syngeneic squamous cell carcinoma has been investigated to clarify the nature of
the local lymphocyte anergy reported previously in this system. Sera from tumour
bearing animals were tested for cytotoxicity against tumour cells by in vitro micro-
assay, and their ability to inhibit cell mediated cytotoxicity was also studied. Serum
cytotoxicity was first detected after 2 weeks of tumour growth, reaching a peak at
4 weeks and then declining. Inhibitory activity was found only in the sera of animals
with advanced tumours. Anti-tumour antibody either in the sera or bound-to tumour
cells was not detected by immunofluorescence techniques. No evidence of general
immunological debilitation was found, the animals showing normal immune respon-
ses to sheep erythrocytes and killed Brucella abortus organisms throughout tumour
growth. Serum inhibitory factors may be responsible for the decline in anti-
tumour immunoreactivity and the local lymphocyte anergy observed in tumour
bearing hosts.
LOCAL lymphocyte anergy has been
reported previously in a study of the
development of cell mediated immunity
to a syngeneic squamous cell carcinoma
in inbred Wistar rats (Flannery et al.,
1973). Regional node lymphocytes, cyto-
toxic to tumour cells early in tumour
growth, lose this ability as the tumour
progresses and become totally unrespon-
sive whereas spleen and bloodlymphocytes
retain a significant degree of cytotoxicity.
It has been shown that factors present in
the sera of tumour bearing hosts interfere
with lymphocyte-mediated tumour-cell
destruction (reviewed by Hellstr6m and
Hellstrom, 1971). These factors include
excess tumour antigen (Alexander, 1970),
anti-tumour antibody (Hellstr6m and
Hellstr6m, 1970) and antigen-antibody
complexes (Baldwin, Price and Robins,
1972; Sjogren et al., 1972). We have
studied the evolution of serum cyto-
toxicity and blockade throughout the
period of tumour growth in rats to investi-
gate any relationship between thesefactors
and regional anergy.
MATERIAL AND METHODS
Animals and tumour.-The growth of a
transplantable squamous cell carcinoma in
Wistar rats and the use of tumour cell sus-
pensions for inoculation and cytotoxicity
assays have been described previously (Flan-
neryetal., 1973).
Tumour growth in vivo.-The pattern of
tumour growth in vivo was studied in 2
groups of animals: (i) Rats inoculated sub-
cutaneously in the medial aspect of the right
thigh with 103 viable tumour cells, previously
shown to produce tumours in all animals and
death in 8-10 weeks. Groups of 4 animals
were killed 2, 4, 6 and 8 weeks after inocula-
tion. (ii) Rats inoculated similarly with
104 viable tumour cells, previously shown to
kill all animals in 6-8 weeks. Groups of
5 animals were killed weekly after tumour
inoculation and the volumes of the primary
tumours were determined (Flannery et al.,
1973).
Immunological studies in vitro
Serum cytotoxicity. Sera were tested for
in vitro complement-dependent cytotoxicity
to tumour cells by a modification of the
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were plated on to microtitration plates
(No. 3034, Falcon Plastics Co.) as described
for the lymphocytotoxicity test (Flannery
et al., 1973). Medium was removed from
each well after 24 hours at 37°C and 5 ,ul of
test, or control normal serum, heat-inactiva-
ted by heating at 56°C for 30 min, was
added by micropipette. After 30 min at
37C, 5 yd ofa 1 in 2 dilution ofreconstituted,
freeze dried guinea-pig complement (Well-
come Laboratories) was added and the
plates reincubated at 37°C for 5 hours.
Plates were then fixed and stained with
Leishman's stain and the number of cells
adhering to the bottom of each well was
counted. Cytotoxicity was expressed as the
percentage reduction in the mean number of
surviving tumour cells in test (Nt) versus
control (Nc) wells, i.e. cytotoxicity
Nc -NtxI 0
Serum blocking activity.-The ability of
sera from tumour bearing animals to inhibit
lymphocyte attack on tumour cells was
assessed by a modification of the method of
Hellstrom et al. (1971). For the lympho-
cytotoxicity test (Flannery et al., 1973), wells
containing approximately 50 tumour cells
were used in all tests and at least 5 replicate
wells were counted. Spleen lymphocytes
were obtained from an immunized syngeneic
donor and stored with 10% dimethyl-
sulphoxide in liquid nitrogen before use.
Although such storage is sometimes associated
with impairment of immunoreactivity of
lymphocytes, in this particular instance, in
comparison with similarly stored normal
lymphocytes, they exhibited a cytotoxicity
of approximately 25%. Before the addition
of the lymphocytes, 10 ,ul of the test serum
(diluted 1 in 5 with medium 199) was added
to each well containing tumour cells, incu-
bated at 37°C for 45 min and removed by
washing. Blocking ability was expressed
as the percentage reduction in cytotoxicity
in test (Ct) versus control (Cc) wells i.e.
blocking =
Cc Ct x 100.
Cc
Student's t-test was used to assess the
statistical significance of differences between
cytotoxicity means, and a difference was
considered significant at the P < 0 05 level.
Membrane immunofuorescence-Mem-
brane staining of viable tumour cells in
suspension treated with the rat sera was
carried out with appropriate controls by
sandwich immunofluorescence described else-
where (Nairn, 1969) using an apparatus
designed to facilitate simultaneous handling
of up to 40 sera (Nairn, Cusdin and Mc-
Naughtan, 1971). A fluorescein labelled
rabbit anti-rat globulin with a fluorescein
to protein molar ratio of 4 3 1 was used at
a globulin concentration of 0 7 g/100 ml.
This conjugate had been absorbed with
human liver powder, bovine liver homogenate
and well washed rat erythrocytes and had
activity against IgG and IgM. By itself
it gave no fluourescent staining of rat tumour
cells or thymocytes.
Frozen sections.-Fresh blocks of tumour,
up to 5 mm square x 2 mm thick, wNere
excised from each ratkilled2, 4, 6 and 8 wNeeks
after inoculation wNith 103 tumour cells.
Blocks were snap frozen in a liquid nitrogen-
isopentane mixture and stored at -70°C.
Sections, 6 [km, were cut and stained by
direct immunofluorescence using standard
controls (Nairn, 1969), and the fluorescein
labelled rabbit anti-rat globulin described
above.
Impression filmsn-Frozen tumour blocks
were thawed to room temperature and
impression films made by pressing the tissue
against gelatinized glass slides (Nairn, 1969).
Films were stained by direct immuno-
fluorescence as for frozen sections.
Antibody responses to other antigens. Four
parallel groups, each of 4 animals wNere
inoculated with 103 tumour cells and injected
intraperitoneally 1, 3, 5 or 7 w%Neeks later with
01 ml of a 50%/ suspension of sheep red
cells (CommonwNealth Serum Laboratories)
and 0-15 ml of a suspension of killed Brucella
abortus (Ring test antigen, Commonwealth
Serum Laboratories). Animals w-ere bled
and killed 7 days after antigen injection.
Antibody activity to sheep red cells ,N'as
determined by haemagglutination assays
wzith 2.5%o red cells in microtitre trays.
Response to Brucella was also determined by
agglutination assay in microtitre trays with a
1 in 250 dilution of the haemotoxylin
stained Brucella preparation.
RESULTS
Tumour growth
The pattern of tumour growth in
both groups of animals was similar.IMMUNE RESPONSE TO A SYNGENEIC RAT TUMOUR
Tumours became palpable 2-4 weeks
after inoculation and then increased
rapidly in volume, reaching a mean size
of 17-1 ± 80 cm3 in the rats inoculated
with 103 cells, and 11b6 + 4-6 cm3 after
104 cells. Metastases were observed
microscopically in the lungs of some
animals when tumours became palpable,
and ofall animals by Week 6.
Serum cytotoxicity
The time course of serum cytotoxicity
is shown in Fig. 1, in which mean values
are plotted. Reactivity reached a peak
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TABLE I.-Development of Humoral Block-
ing Reactivity by Tumour Bear-ing
Rats (103 Tumour CellInoculum)
Week
Reduction of
lymphocytotoxicity
(%)
2 4 6 8
0 0 0 52*
7 4 0 60t
9 12 7 72t
15 42* 49 ...
... Not tested.
* Significant, P < 0 05.
t Significant, P < 0-01.
TABLE II.-Development ofHumoralBlock-
ing Reactivity by Tumour Bearing
Rats (104 Tumour CellInoculum)
Week
Reduction of
lymphocytotoxicity
(%)
* Significant, P < 0 05.
t Significant,P < 0-01.
Duration of tumour growth (weeks)
FIG. 1.-Evolution of serum cytotoxicity during
tumour growth in rats after inoculation with 103
tumour cells (0 *, means of 4 animals) and
104 tumour cells (---*, means of 5 animals).
Means ± standard error.
in 1oth groups ofanimals at Week 4, after
which it declined and was not significant
beyond Week 6. No cytotoxicity was
demonstrable in the absence of comple-
ment.
Serum blockade of lymphocyte cytotoxicity
The ability of sera from tumour bear-
ing animals to inhibit the lymphocyto-
toxicity reaction is summarized in Tables
I and II. The sera from animals inoculated
with 103 tumour cells showed no inhibition
until Week 8, by which time all animals
tested were positive; an exception was
the serum of one animal which was
21
1 2 3 4 5 6 7
0 0 0 0 0 0 0
0 0 0 0 0 0 19
0 1 18 2 0 0 93t
10 2 33 7 0 0100*
12 57 36 23 5 29 100t
inhibitory at Week 4. Animalsinoculated
with 104 tumour cells showed no serum
inhibitory activity until Week 7, when
3 of 5 sera tested were positive.
Antibodies to tumour
Despite demonstrable in vitro cyto-
toxicity of the sera from many tumour
bearing animals against tumour cells,
no anti-tumour cell membrane antibodies
were detected by membrane immuno-
fluorescence, which is doubtless a less
sensitive index of antibody binding. No
antibody pre-bound to cells was demon-
strable in either frozen sections or impres-
sion films oftumour.
Response to sheep erythrocyte and Brucella
abortus antigens
The antibody responses of tumour
bearing rats to sheep red blood cells and
Brucella abortus during tumour growth
are summarized in Table III. The results
show that the levels of response did not
differ significantly at any time from those
of control, non-tumour bearing rats. An
apparent deviation in the response to
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TABLE III.-Reactivity of Tumour Bearing
Rats against Sheep Red Blood Cells
and Killed Brucella abortus Organ-
isms. JMeans of4 animals
Log2 titre (range and mean)
Week Sheep red cells Brucellot abortus
2 8-10 (9) 11-13 (12)
4 8-9 (8) 11-14 (13)
6 6-8 (8) 10-13 (12)
8 1*-9 (6) 11-14 (13)
Normal controls 8-10 (9) 11-14 (13)
(10 animals)
* Titre of 1 rat only below normal range.
sheep red cells at Week 8, due to a low
titre in one rat, was not statistically
significant.
DISCUSSION
We have studied the development, in
tumour bearing hosts, of serum factors
capable of tumour cell destruction and
factors able to inhibit lymphocyte cyto-
toxicity. Serum mediated cytotoxicity
became apparent early in tumour growth
and then declined. The size of the initial
tumour inoculum did not alter this
pattern. A similar time course has been
reported for the development of lympho-
cytotoxicity in these animals (Flannery
et al., 1973).
The complement dependence of the
serum cytotoxicity and the work of
others (Takasugi and Hildemann, 1969;
Ankerst, 1971) implicate antibodies in
this reaction. The serum concentration
of such antibodies was in any case low,
as no activity against tumour cell mem-
brane antigens was detected by immuno-
fluorescence. In view of the similar
decline in lymphocyte cytotoxicity, the
observed reduction in serum reactivity
may have been due to a lymphocyte
impairment, either as a direct B cell
deficiency or as a defect in T cell collabora-
tion. A general immunological debilita-
tion, however, was not demonstrated:
normal antibody responses were main-
tained in tumour bearing animals to
Brucella abortuas, a measure primarily of B
cell function (Crewther and Warner, 1972;
Hard, G. C. personal communication) and
to sheep erythrocytes, a function requir-
ing T and B cell co-operation (Claman and
Chaperon, 1969). An alternative hypo-
thetical explanation, which has not yet
been studied, would be a shift in the
production of IgM antibody to less lytic
IgG antibody during maturation of the
immune response (Takasugi and Hilde-
mann, 1969; Ankerst, 1971).
Inhibition of lymphocyte cytotoxicity
by sera of tumour bearing animals was
seen in later stages of tumour growth.
We have not yet investigated the nature
of the serum blocking factors in our sys-
tem, but their occurrence may be another
explanation for the decline in anti-
tumour immunoreactivity. The late de-
tection of blocking may have been due
to the relatively low sensitivity of the
technique used, as others (Sjogren and
Borum, 1971) have reported the appear-
anceofblockingfactorsthroughouttumour
growth. Alternatively, the appearance of
blocking factors and the disappearance of
cytotoxic antibody may be associated with
the concurrent growth ofmetastases. The
possibility of " unblocking factors " (Hell-
strom and Hellstrom, 1970; Bansal and
Sjogren, 1971) earlier in tumour growth
has not been investigated in our system.
In vivo, blocking factors might act
on effector lymphocytes or on tumour
cells. Circulating lymphocytes will be
more accessible to humoral factors and
specific depression of lymphocytes has
been described (Field and Caspary, 1972).
Currie and Basham (1972) have demon-
strated that washing of lymphocytes from
cancer patients increased their cytotoxic
activity; subsequent incubation of the
prewashed lymphocytes with autologous
serum abolished this reactivity. The
anergy of local lymphocytes in our system
(Flannery et al., 1973) may well be due
to lymphocyte inhibition of this type.
Blocking factors have been detected by
us and by others (e.g. Hellstrom et al., 1971)
which bound to target cells, and eluates
from tumour cell suspensions have been
shown to possess in vitro and in vivoIMMUNE RESPONSE TO A SYNGENEIC RAT TUMOUR 297
blocking reactivity (Bansal, Hargreaves
and Sj6gren, 1972; Ran and Witz, 1972;
Sjogren et al., 1972). Others (Hellstrom
and Hellstrom, 1969; Cohen, Millar and
Ketcham, 1972) have demonstrated block-
ing by incubation of tumour cells with
serum but failed to show inhibition by
similar incubation of lymphocytes. Such
tumour bound factors cannot account
for the lymphocyte anergy we observed
and their in vivo significance is unclear.
Evidence that inhibitory factors may be
antigen-antibody complexes (Sjogren et
al., 1971, 1972; Baldwin et al., 1972)
suggests that they might be able to act
on lymphocytes whilst bound to tumour
cells (Sjogren et al., 1972). In our studies,
binding of antibodies to lymphocytes or
tumour cells was not detected by im-
munofluorescence, presumably due, if
present, to their low in vivo levels.
We have shown a local lymphocyte
anergy and the presence in serum of
factors capable of inhibiting lympho-
cytotoxicity. If blocking factors are re-
sponsible for in vivo loss of lymphocyte
reactivity, there must be some local
component to account for the early
development of anergy in the regional
nodes. This local factor seems most
likely to be excess tumour antigen which
may then pass into the serum, perhaps
complexed with antibody, as the inhibitor
we have detected. The isolation and
characterization of this factor(s) are
proceeding.
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